Freeway
Arizona

Tucson

Data as of Oct 1, 2026
715
Companies
$10.0M
Venture funding in the last 12 months, 2 rounds
$94.7M
Venture funding, 2022–2026
32
Investor firms

Venture funding by year

* 2026 through Oct 2026. Rounds without a disclosed amount count as rounds, not dollars.
Show as a table
YearVenture fundingRounds
2019$14.1M12
2020$29.2M11
2021$19.9M11
2022$35.6M9
2023$3.7M7
2024$28.2M11
2025$17.2M6
2026*$10.0M2

Industries

  • Health126
  • Energy46
  • Education37
  • Semiconductors37
  • Fintech34
  • Food30
  • Enterprise software29
  • Real estate26
  • Kids22
  • Security17

And 19 more industries.

Companies in Tucson

73–96 of 715 companies

  • Azurepoland

    Security

    Early stage

  • Azuro

    Fintech

    Azuro operates as a decentralized, on-chain predictions layer, providing infrastructure and liquidity for developers to build prediction and gaming applications on EVM-compatible blockchains like Polygon and Gnosis Chain. Founded in 2021 by a team including Paruyr Shahbazyan, Rossen Yordanov, and Dmitry Globenko, the protocol was established to address transparency and liquidity challenges prevalent in traditional betting markets. Shahbazyan, with a background as a professional sports bettor and the founder of Bookmaker Ratings, an online media platform for the betting industry, was motivated by his experiences with the opaqueness of centralized bookmakers. Yordanov transitioned from a corporate role in online payments, where he led crypto development, to co-found Azuro, driven by a desire to work more deeply within the on-chain environment. The company's business model is structured as a B2B protocol, offering modular tooling and oracle solutions that enable third parties to create and monetize user-facing applications without initial or ongoing costs. Revenue is generated from transaction fees within the ecosystem, boasting an average take rate of 4.28%. As of June 2024, the protocol had facilitated over $358 million in prediction volume across more than 4.8 million transactions, generating $3.4 million in total revenue. Azuro has secured $11 million in total funding from investors such as Fenbushi Capital, Hypersphere Ventures, Delphi Digital, and Gnosis. Azuro's core technology revolves around a peer-to-pool liquidity model called the Liquidity Tree, which aggregates capital from liquidity providers (LPs) to ensure there is always a counterparty for bets, thus solving a critical liquidity problem in peer-to-peer prediction markets. LPs provide single-sided liquidity, typically in stablecoins, and in return, earn a yield based on the protocol's overall performance. All transactions are executed via smart contracts for transparency. Bets are represented as non-fungible tokens (NFTs), which allows for features like parlays and cashouts, and opens up possibilities for secondary markets and gamification. For developers, Azuro provides a Software Development Kit (SDK) with pre-built web components to facilitate the creation of decentralized applications (dApps) on its protocol. Governance is handled by the AzuroDAO, which involves the community in key decisions.

    Early stage · 11–50 employees · $7.5M raised

  • Early stage · 2–10 employees

  • Early stage · 11–50 employees

  • Early stage

  • Bellautomotive

    Transportation

    Bell Automotive is a company specializing in high-quality automotive accessories, catering to consumers looking to enhance their vehicle's functionality and aesthetics. The company operates in the automotive aftermarket industry, providing a wide range of products such as seat covers, steering wheel covers, license plate frames, fasteners, organizational solutions, 12-volt accessories, sun protection, and tire repair solutions. Bell Automotive's product line includes intelligent tire inflators with Smart technology and interior accessories available in popular licensed brands. The company serves a diverse clientele, from everyday drivers seeking to add style to their vehicles to families prioritizing safety and organization. Bell Automotive's business model revolves around direct sales to consumers through various retail channels, both online and offline, generating revenue from the sale of its diverse product range. The company differentiates itself through extensive consumer research, ensuring that its designs are preferred over existing market options and offering better-fitting sunshades that protect vehicle interiors from harsh sunlight damage.

    Early stage · 11–50 employees

  • Early stage · 2–10 employees

  • Bhive

    Enterprise software

    Early stage · 11–50 employees

  • Binette Technologies

    Enterprise software

    Binette Technologies provides a 'Growth AI Operating System' designed to give small and medium-sized businesses (SMBs) the operational capabilities of larger enterprises without the associated overhead. The company was founded by Moses Narteh, who, after observing the struggles of SMB operators with disconnected tools and manual processes, aimed to create a unified, self-configuring AI platform. His mission is to address the digital divide that leaves over 99% of U.S. businesses underserved by complex and expensive AI solutions. The firm is incorporated in Arizona and operates out of Tucson. Its business model is centered on a flat monthly subscription, which provides a cost-effective alternative to the multiple, expensive software tools that businesses typically use. Binette Technologies targets service-driven sectors where rapid customer response and efficient follow-up are critical, including home services, professional services like law and real estate, and health and wellness. The platform is designed to be operational within 48 hours, requiring clients only to connect their website and upload business information to activate the system. The core of Binette Technologies' offering is a consolidated platform that integrates several key functions. Its architecture is built on modern technologies like Next.js 15 and Supabase, using a model-agnostic AI framework that leverages top large language models (LLMs) such as Gemini, Claude, and GPT. The system features autonomous agents that execute complete workflows rather than just providing simple dashboards. Key products include 'AVA Voice' for handling phone calls, 'AVA Chat' for web and SMS interactions, 'FlowEngine' for business automation, and 'PageEdit' for website management. This is supplemented by a suite of tools for local SEO, social media management, reputation management, and CRM integration, creating a single, cohesive engine for business growth.

    Early stage

  • Biosaz

    Health

    Early stage

  • Early stage · 2–10 employees · $220K raised

  • Early stage · 1 employees

  • BioVigilant specializes in instantaneous microbial contamination detection for pharmaceutical water systems, offering real-time bioburden data to ensure the health and performance of high-purity water systems. Founded in 2002, BioVigilant serves clients in the biopharmaceutical and pharmaceutical industries, providing innovative solutions to enhance manufacturing processes and ensure product safety. The company operates in the niche market of microbial detection and monitoring, leveraging advanced technologies like online water bioburden analyzers (OWBAs) to deliver continuous, real-time monitoring. BioVigilant's business model revolves around selling these high-tech instruments and offering related services, generating revenue through equipment sales, maintenance contracts, and consulting services. The company’s offerings are critical for clients focused on maintaining stringent quality standards and regulatory compliance in their production environments.

    Early stage · 2–10 employees · $6.7M raised

  • BioXgen

    Health

    BioXgen is a medical device company developing solutions for post-operative complications in cardiac surgery. The company was incorporated in Delaware on June 13, 2025. The company's flagship product is a patent-pending extracellular matrix (ECM)-based cardiac patch designed to support recovery after open-heart procedures. This patch, derived from porcine tissue, is intended to mitigate post-operative atrial fibrillation (POAF), a common complication affecting a significant percentage of cardiac surgery patients. POAF can lead to longer hospital stays, increased risk of stroke, and other adverse outcomes. The device provides structural support to the heart during the critical recovery period and is applied directly to the heart before closing the chest. BioXgen operates on a standard medical device revenue model, planning to sell the cardiac patch directly to hospitals and cardiac surgery centers. The pricing will be structured on a per-procedure basis, aiming to provide a clear return on investment for hospitals by reducing costs associated with managing complications like POAF. The market for managing POAF is substantial, with approximately 500,000 open-heart surgeries performed in the U.S. annually. The company is pursuing an accelerated regulatory pathway, leveraging an FDA 510(k) predicate device to expedite market entry, with a target for FDA clearance in 2026. Preclinical validation in large animal models and a clinical proof-of-concept study have been completed. Funds from its current offerings are intended to support clinical trials, product development, and operations to achieve FDA clearance and initial commercialization.

    Early stage

  • Early stage

  • Early stage · 1 employees

  • Early stage · 2–10 employees

  • BizChickBlogs

    Fashion, Media

    Early stage · 2–10 employees

  • Early stage

  • AZ Black Labs operates in the analytical testing industry, focusing on providing advanced testing solutions for the cosmetics sector. Utilizing cutting-edge technologies such as Artificial Intelligence (AI) and Machine Learning (ML), the company addresses complex testing challenges, ensuring the safety and quality of cosmetic products. AZ Black Labs serves a diverse clientele, including cosmetics manufacturers and regulatory bodies, offering services that guarantee rigorous evaluation, compliance, and verification of cosmetic formulations. The business model revolves around partnering with clients from the inception of their products, delivering precise and reliable results that meet industry standards. Accredited under the International Standard ISO/IEC 17025:2017, AZ Black Labs emphasizes accuracy and quality in its chemical testing services, making it a trusted partner in the dynamic cosmetics market.

    Early stage

  • Both founders transitioned from careers in the Information Technology industry, a field they each worked in for nearly two decades, to pursue their passion for brewing which began with home brewing starter kits. Their goal was to establish a production brewery and a tasting room on the east side of Tucson, an area they identified as an underserved segment of the city's growing craft beer market. The company operates as a microbrewery with a 15-barrel capacity, focusing on producing and distributing craft beers to local and regional venues. The business model centers on running a taproom where customers can purchase and enjoy a variety of beers, and distributing its products to build brand recognition. BlackRock Brewers has secured funding through various means, including an angel investment of $82.5K in August 2018 and product crowdfunding. Their product line includes a range of flagship and seasonal beers. Flagship offerings include the "#Dangeruice" Rye IPA, "Full Effect" Hazy IPA, and the award-winning "Tartan 99" Scottish Ale. The brewery also offers a rotating selection of seasonal beers, such as the "DogHouse" Peanut Butter Milk Stout in the winter and the "El Heffe" Green Chili Wheat in the summer, alongside other unique creations like a vanilla-infused porter and various IPAs.

    Early stage · 2–10 employees · $30K raised

  • Early stage · 2–10 employees

  • Early stage · 2–10 employees

  • Early stage · 11–50 employees

Recent venture rounds

CompanyRoundAmountDateInvestors
World View EnterprisesLate VC$10.0MMar 2026Ondas Holdings
KeysEarly VCUndisclosedMar 2026Not disclosed
Revolute RoboticsSeed$1.9MOct 2025ANIMO Ventures, Ascend VC
Delta Development TeamSeries AUndisclosedAug 2025Pasadena Angels, Desert Angels, Central Texas Angel Network +3 more
TYBSeries A$11.0MJun 2025Coinbase Ventures, Unusual Ventures, Castle Island Ventures +2 more
T&R Recovery GroupGrowth Equity VCUndisclosedJun 2025Cyprium Investment Partners, Genesis Park
Branch TherapeuticsSeed$4.0MMay 2025GKCC
SorbiforceSeed$270KApr 2025StartEngine
Precision EpigenomicsSeries A$1.5MSep 2024Shaffer Capital
World View EnterprisesLate VC$25.0MMay 2024Breakthrough Victoria
Investors based here
Accelerators and programs

Source: Dealroom, data as of Oct 1, 2026. Venture funding sums venture-type rounds with a disclosed amount; rounds raised by companies already public or bought out are left out. The last 12 months run from Nov 2025 to Oct 2026.

Founders, team members and individual investors are never shown, and company descriptions have sentences naming people removed.